The promise of exosome applications in treating central nervous system diseases

Jared Mattingly,Yuchen Li,Ji C. Bihl,Jinju Wang,Jared Mattingly,Yuchen Li,Ji C. Bihl,Jinju Wang
DOI: https://doi.org/10.1111/cns.13743
2021-10-12
Abstract:Exosomes (EXs), a type of extracellular vesicles, are secreted from virtually all types of cells. EXs serve as cell-to-cell communicators by conveying proteins and nucleic acids with regulatory functions. Increasing evidence shows that EXs are implicated in the pathogenesis of central nervous system (CNS) diseases. Moreover, EXs have recently been highlighted as a new promising therapeutic strategy for in vivo delivery of nucleotides and drugs. Studies have revealed that infusion of EXs elicits beneficial effects on the CNS injury animal models. As compared to cell-based therapy, EXs-based therapy for CNS diseases has unique advantages, opening a new path for neurological medicine. In this review, we summarized the current state of knowledge of EXs, the roles and applications of EXs as a viable pathological biomarker, and EX-based therapy for CNS diseases.
pharmacology & pharmacy,neurosciences
What problem does this paper attempt to address?